Anbio Biotechnology Class A Ordinary Shares (NNNN) Stock Analysis

Anbio Biotechnology Class A Ordinary Shares (NNNN) is a publicly traded company in the HEALTHCARE sector. It trades at $32.12, carries a market capitalization of $1.32B, a price-to-earnings ratio of 201.13. This page summarizes the public market data, fundamentals, and frequently asked questions for NNNN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NASDAQ

Key Metrics

• Price: $32.12
• Market Cap: $1.32B
• P/E Ratio: 201.13
• EPS: $0.15
• 52-Week High: $55.65
• 52-Week Low: $7.92

Market Sentiment

Anbio Biotechnology Class A Ordinary Shares currently has a Neutral sentiment score of -0.10.

About Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares is a leading developer and distributor of innovative in vitro diagnostic (IVD) products, with a significant global presence across regions including the European Union, Asia Pacific, North America, South America, and Africa. Based in Frankfurt am Main, Germany, the company is dedicated to enhancing healthcare through state-of-the-art diagnostic solutions, positioning itself as a pivotal player in the biotechnology industry. With a comprehensive prod...

GNG Research Analysis

GNG Research scores Anbio Biotechnology Class A Ordinary Shares (NNNN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NNNN.

Frequently Asked Questions

Does NNNN pay dividends?

Anbio Biotechnology Class A Ordinary Shares (NNNN) does not currently pay a regular dividend.

What is NNNN's P/E ratio?

Anbio Biotechnology Class A Ordinary Shares has a price-to-earnings (P/E) ratio of 201.13.

What is NNNN's market cap?

Anbio Biotechnology Class A Ordinary Shares (NNNN) has a market capitalization of $1.32B with a current stock price of $32.12.